Investor Presentaiton
Type 2 Diabetes: 3 Elements of an Effective Solution
میرا
User Engagement
Sustained engagement demonstrated
in non-intensive studies
Example: MOBILE results suggested patient
engagement was the most likely source of
improved glycemic control¹
Health Outcomes
Evidence generation through clinical
trials, real-world evidence, and pilots
with key partners
Example: Recent study demonstrated broad
cardiometabolic outcomes with improved
glucose control²
Return on Investment
Strong economic return to payers
Example: Multiple studies demonstrate cost
savings per member per month of $400+3,4
1.
https://jamanetwork.com/journals/jama/article-abstract/2780595
2. Majithia et al., "Glycemic Outcomes in Adults With Type 2 Diabetes Participating in a Continuous Glucose Monitor-Driven Virtual Diabetes Clinic: Prospective Trial," JMIR 22:8 (2020).
3.
Compared to SMBG cohort. For the published results see Isaacson B, Kaufusi S, Sorensen J, et al. Demonstrating the Clinical Impact of Continuous Glucose Monitoring Within an Integrated Healthcare Delivery System. JD ST. September 2020.
4. Includes real-world claims data for a combination of Type 2 intensive and non-intensive Dexcom customers. Link here
Dexcom
22
22View entire presentation